Keyphrases
Extent of Disease
100%
Overall Survival
100%
Bone Metabolism Markers
100%
MiR-223
100%
Bone Metabolism Biomarker
100%
Radium-223
83%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
66%
Bone Alkaline Phosphatase
50%
Median Overall Survival
50%
Clinical Outcomes
33%
Procollagen Type 1 N-terminal Propeptide (P1NP)
33%
Osteocalcin
33%
C-terminal Telopeptide of Type I Collagen
33%
Bone Scan Index
33%
Radium-223 Therapy
33%
Symptomatic Skeletal Events
33%
Blood Samples
16%
Surrogate Marker
16%
Bone Turnover Markers
16%
Patient Selection
16%
Matrix Metalloproteinases
16%
Outcome Prediction
16%
Response Assessment
16%
Prostate Cancer Patients
16%
Radionuclide Therapy
16%
Osteoprotegerin
16%
Nuclear factor-B
16%
Overall Time
16%
Disease Survival
16%
Linear Association
16%
Sclerostin
16%
Bone Matrix
16%
Predictive Information
16%
Skeletal Disorders
16%
Therapeutic Change
16%
Survival Median
16%
α-emitting Radionuclides
16%
TRACP-5b
16%
Medicine and Dentistry
Disease
100%
Biological Marker
100%
Overall Survival
100%
Bone Remodeling
100%
Castration Resistant Prostate Cancer
44%
Alkaline Phosphatase
33%
Bone Scintigraphy
22%
Collagen Type 1
22%
Osteocalcin
22%
Procollagen
22%
Prospective Study
11%
Disease Marker
11%
Osteolysis
11%
Receptor
11%
Nuclear Factor
11%
Radionuclide Therapy
11%
Matrix Metalloproteinase
11%
Alternative Complement Pathway C3 C5 Convertase
11%
Cross-Link
11%
Osteoprotegerin
11%
Carboxy Terminal Sequence
11%
Bone Disease
11%
C-Terminal Telopeptide
11%
Telopeptide
11%
Sclerostin
11%
Bone Matrix
11%
Osteoclast Differentiation Factor
11%
Acid Phosphatase Tartrate Resistant Isoenzyme
11%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Biological Marker
100%
Overall Survival
100%
Castration Resistant Prostate Cancer
44%
Alkaline Phosphatase
33%
Procollagen
22%
Osteocalcin
22%
Collagen Type 1
22%
Telopeptide
22%
Prospective Study
11%
Disease Marker
11%
Receptor
11%
Nuclear Factor
11%
Osteoprotegerin
11%
Matrix Metalloproteinase
11%
Alternative Complement Pathway C3 C5 Convertase
11%
Radioisotope
11%
Bone Disease
11%
Osteoclast Differentiation Factor
11%
Sclerostin
11%
Acid Phosphatase Tartrate Resistant Isoenzyme
11%
Biochemistry, Genetics and Molecular Biology